New Moscow University Technique Predicts Stem Cell Fate to Prevent Tumors Before Injection

Researchers at Moscow State University (Lomonosov) have achieved a significant advancement in regenerative medicine by creating an innovative technique that allows precise prediction of stem cell differentiation pathways and quality assessment shortly before their therapeutic application. This new method addresses a longstanding medical challenge of monitoring cell differentiation and determining their final fate.

The approach employs an artificial protein that acts as a fluorescent marker, safely binding to the cells' DNA without causing toxicity, unlike traditional dyes previously used. Laboratory experiments demonstrated the safety and effectiveness of this protein, enabling continuous observation of cell behavior over a 13-day period.

Remarkably, the researchers were able to sort cells and obtain accurate results by the second day of the experiment. This early separation distinguishes cells destined to become bone tissue from those that will develop into fat tissue, providing physicians with enhanced control and precise guidance over therapeutic outcomes.

The clinical significance of this technique lies in its ability to verify the safety and uniformity of cells prior to injection. This capability improves the efficiency of heart tissue repair and treatment of complex fractures while minimizing the risk of side effects, primarily tumor growth. Additionally, the innovation plays a crucial role in addressing imbalances between bone and fat formation caused by aging or disease, where fat accumulates in bone marrow leading to fragility.

The technology ensures thorough examination of target cells, confirming their full compliance with required specifications and maturity. This guarantees safe and orderly reconstruction of damaged tissues.